Eighth Edition - R.3 - Human Fertilisation & Embryology Authority
Eighth Edition - R.3 - Human Fertilisation & Embryology Authority
Eighth Edition - R.3 - Human Fertilisation & Embryology Authority
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HFEA guidance (cont)<br />
Confidentiality<br />
12.12 In addition to following standard procedures for protecting patient and donor confidentiality, the centre<br />
should ensure it keeps all notes, facilities and procedures for the egg provider separate from those for the<br />
recipient(s). Care should be taken to ensure that confidentiality is not compromised, for example, if the egg<br />
provider and recipient(s) are treated at the same centre at the same time.<br />
See also guidance note:<br />
<br />
30 – Confidentiality and privacy<br />
Egg sharing agreements<br />
12.13 The centre should draw up separate agreements with the egg provider and with the egg recipient(s).<br />
These agreements should be consistent with each other. The centre should abide by the terms<br />
of egg sharing agreements it has made.<br />
Agreement between a licensed centre and an egg provider<br />
12.14 When drawing up agreements between the centre and egg providers, centres should seek legal advice.<br />
12.15 The agreement between the centre and the egg provider should set out all the terms of the arrangement.<br />
It should identify clearly the egg provider and the centre, and be signed by both parties.<br />
12.16 The agreement should include a statement confirming:<br />
(a) that any patient who has consented to providing eggs for the treatment of others<br />
in licensed treatment under the HFE Act 1990 (as amended) will not be the legal<br />
parent of any resulting child(ren)<br />
(b)<br />
(c)<br />
what information will be available to the egg provider about the recipient and the outcome of<br />
her treatment, for example the number and sex of any resulting children, and<br />
what information will be available to the egg recipient about the egg provider and the<br />
outcome of her treatment, for example the number and sex of any resulting children.<br />
12.17 The agreement should include a full description of what the treatment is expected to involve, including:<br />
(a) the number of treatment cycles covered by the agreement, and<br />
(b)<br />
the expected waiting time for treatment.<br />
12.18 The agreement should include a statement from the egg provider confirming that she has:<br />
(a) had an opportunity to talk with a member of staff qualified to explain the procedures involved<br />
in providing her eggs as part of an egg sharing arrangement<br />
(b)<br />
(c)<br />
(d)<br />
(e)<br />
received verbal and written information about her treatment<br />
received all the appropriate information listed in the relevant parts of this Code of Practice<br />
been offered counselling about the implications of the treatment, and<br />
been made aware of the screening that will be done before treatment begins.<br />
See also guidance notes:<br />
<br />
<br />
4 – Information to be provided prior to consent<br />
11 – Donor recruitment, assessment and screening<br />
<strong>Human</strong> <strong>Fertilisation</strong> and <strong>Embryology</strong> <strong>Authority</strong><br />
Guidance note | 12. Egg sharing arrangements<br />
Version 1.0